Using data from the Alzheimer’s disease neuroimaging initiative (ADNI) we here report the prevalence of abnormal tau PET binding in individuals classified as being cognitively unimpaired [CU] or having mild cognitive impairment [MCI] or Alzheimer’s disease dementia. Here, MAPT is linked to Alzheimer disease.